DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Death receptor 4
Death receptor 4
The Role of Immunogenic Cell Death
Download
Download
Activating Death Receptor DR5 As a Therapeutic Strategy for Rhabdomyosarcoma
Potential Tumor-Promoting Effects of Ectopic Cd137 Expression on Hodgkin Lymphoma
(TRAIL) Death Receptor-4 and Promotes Apoptosis Resistance in Cholangiocarcinoma
Biolegend.Com
Targeting TRAIL Death Receptor 4 with Trivalent DR4 Atrimer Complexes
Death Receptor 4 and Bladder Cancer Risk1
Theranostics Downregulation of Death Receptor 4 Is Tightly Associated With
(Ciap-1) Degradation by Caspase 8 During TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis
Abcl 73 Acquired Immunodeficiency Syndrome (AIDS) 73 Acute Tubular
Activation of Nuclear Factor-KB Contributes to Induction of Death Receptors and Apoptosis by the Synthetic Retinoid CD437 in DU145 Human Prostate Cancer Cells
Cell Structure & Function
Death Receptor 5, a New Member of the TNFR Family, and DR4 Induce FADD-Dependent Apoptosis and Activate the NF-B Pathway
A Novel Agonistic Antibody to Human Death Receptor 4 Induces Apoptotic Cell Death in Various Tumor Cells Without Cytotoxicity in Hepatocytes
Apo2l/TRAIL and Its Death and Decoy Receptors
8 Death Receptor Mutations
Top View
The Role of Immunogenic Cell Death
Regulation of TRAIL-Receptor Expression by the Ubiquitin-Proteasome System
Exploiting the Extrinsic and the Intrinsic Apoptotic Pathways for Cancer Therapeutics
Apoptotic and Antitumor Activity of Death Receptor Antibodies Require Inhibitory Fcγ Receptor Engagement
The Role of the Costimulatory TNFR Family Member GITR in T Cell Immunity During an Acute Respiratory Infection
Tumors Anti-DR5 Antibody Therapy in Established Contribute to The
Death Receptor Agonists As a Targeted Therapy for Cancer
Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer
Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy
Signal Transduction by Tumour Necrosis Factor and Tumour Necrosis Factor Related Ligands and Their Receptors
16 Expression and Regulation of Death Receptors in Multiple Myeloma and Prostate Carcinoma
The TRAIL Apoptotic Pathway in Cancer Onset, Progression and Therapy
Prognostic Significance of Serum Soluble DR5 Levels in Small-Cell Lung Cancer Zhenfa Wan1,#, Xiaoshan Zhang2,#, Xinshuang Yu3, Yong Hou3,
Differential Susceptibility of Gastric Cancer Cells to TRAIL-Induced Apoptosis
Roles of TNF-Related Apoptosis-Inducing Ligand in Experimental Autoimmune Encephalomyelitis
THE CONCISE GUIDE to PHARMACOLOGY 2017/18: Catalytic Receptors
New Insights Into Apoptosis Signaling by Apo2l/TRAIL
The Emerging Role of New Protein Scaffold-Based Agents for Treatment of Cancer ULRICH H
Epigenetic Dynamics of the Infant Immune System Reveals a Tumor Necrosis Factor Superfamily Signature in Early Human Life
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
Death Receptor 5 (TNFRSF10B)
Catalytic Receptors
Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis
Death Receptor 4 (DR4) Efficiently Kills Breast Cancer Cells Irrespective Of
DR5) Contribute Differently to TRAIL-Mediated Apoptosis
Targeting Death-Inducing Receptors in Cancer Therapy
Ligand Through TNF-Related Apoptosis-Inducing Production in T
Role of TRAIL-Receptors in Apoptosis and Nonapoptotic Signaling in Cancer Cells Populations Undergoing Fractional Killing Yelyzaveta Shlyakhtina
Molecular Mode of Action of TRAIL Receptor Agonists—Common Principles and Their Translational Exploitation
Dynamic Assessment of Nk Cell Interactions with Pediatric Tumor Cells to Predict Response to Immunotherapy
Glycosylation Modulates TRAIL-R1/Death Receptor 4 Protein: Different Regulations of Two Pro-Apoptotic Receptors for TRAIL by Tunicamycin
View on the Meaning of F3 Func- Diseases [36]
Epigenetic Silencing of Death Receptor 4 Mediates Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance in Gliomas Agnes Elias,1 Markus D
Death Receptor 4 Growth in Vivo by Monoclonal Antibodies to Isotype
Implication of NF-Κb and P53 in the Expression of TRAIL-Death
Membrane-Proximal Cytoplasmic Domain of Fas Kinases That
WO 2018/056821 Al 29 March 2018 (29.03.2018) W !P O PCT
Role of Fas and RANKL Signaling in Peripheral Immune Tolerance
Death Receptor 4 (DR4) Polyclonal Antibody #: CATALOG AMOUNT: Freeze/Defrost Cycles
Enhancing the Antitumor Efficacy of a Cell-Surface Death Ligand by Covalent Membrane Display
CPC Notice of Changes 234-DP0077 (C07K)
Tumour Necrosis Factor (TNF) Receptor Family (Version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Akkermansia Muciniphila Aspartic Protease Amuc 1434* Inhibits Human Colorectal Cancer LS174T Cell Viability Via TRAIL-Mediated Apoptosis Pathway